Resumen de acción METROPOLIS
Metropolis Healthcare Limited presta servicios de diagnóstico en la India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Competidores de Metropolis Healthcare Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,805.05 |
| 52 Week High | ₹1,933.50 |
| 52 Week Low | ₹1,209.25 |
| Beta | 0.30 |
| 1 Month Change | 4.73% |
| 3 Month Change | 14.12% |
| 1 Year Change | 44.23% |
| 3 Year Change | -24.63% |
| 5 Year Change | 89.98% |
| Change since IPO | 88.06% |
Noticias y actualizaciones recientes
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Rentabilidad de los accionistas
| METROPOLIS | IN Healthcare | Mercado IN | |
|---|---|---|---|
| 7D | 3.8% | 0.8% | 2.4% |
| 1Y | 44.2% | 61.3% | 45.0% |
Rentabilidad vs. Industria: METROPOLIS obtuvo unos resultados inferiores a los del sector Indian Healthcare , que el año pasado arrojó un rendimiento del 65.6%.
Rentabilidad vs. Mercado: METROPOLIS igualó al mercado Indian, que obtuvo un rendimiento del 45% el año pasado.
Volatilidad de los precios
| METROPOLIS volatility | |
|---|---|
| METROPOLIS Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: METROPOLIS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de METROPOLIS (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1981 | 4,300 | Surendran Chemmenkotil | www.metropolisindia.com |
Metropolis Healthcare Limited presta servicios de diagnóstico en la India. Ofrece pruebas de laboratorio clínico y perfiles y servicios de apoyo. La empresa ofrece servicios de diagnóstico para oncología, neurología, ginecología y nefrología, así como diversos paquetes de chequeos médicos para hombres, mujeres, personas mayores, jóvenes y empresas.
Resumen de fundamentos de Metropolis Healthcare Limited
| Estadísticas fundamentales de METROPOLIS | |
|---|---|
| Capitalización bursátil | ₹92.47b |
| Beneficios(TTM) | ₹1.25b |
| Ingresos (TTM) | ₹11.59b |
74.1x
Ratio precio-beneficio (PE)8.0x
Ratio precio-ventas (PS)¿Está METROPOLIS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de METROPOLIS | |
|---|---|
| Ingresos | ₹11.59b |
| Coste de los ingresos | ₹2.56b |
| Beneficio bruto | ₹9.03b |
| Otros gastos | ₹7.79b |
| Beneficios | ₹1.25b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 24.35 |
| Margen bruto | 77.94% |
| Margen de beneficio neto | 10.76% |
| Ratio deuda/patrimonio | 22.0% |
¿Cómo se ha desempeñado METROPOLIS a largo plazo?
Ver rendimiento histórico y comparativa